Gainers
- WAVE Life Sciences (NASDAQ:WVE) stock increased by 53.7% to $3.92 during Thursday's regular session. Trading volume for this security as of 13:31 EST is 1.3 million, which is 268.9% of its average full-day volume over the last 100 days. The company's market cap stands at $339.9 million. As per the press release, Q2 earnings came out today.
- T2 Biosystems (NASDAQ:TTOO) shares rose 42.53% to $0.23. As of 13:31 EST, T2 Biosystems's stock is trading at a volume of 391.3 million, which is 2056.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.6 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) shares moved upwards by 35.32% to $0.61. Nymox Pharmaceutical's stock is trading at a volume of 1.1 million shares as of 13:31 EST. This is 253.7% of its average full-day volume over the last 100 days. The company's market cap stands at $54.9 million.
- Absci (NASDAQ:ABSI) shares increased by 32.72% to $5.57. Trading volume for Absci's stock is 12.6 million as of 13:31 EST. This is 3028.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $517.6 million. As per the news, the Q2 earnings report came out today.
- UpHealth (NYSE:UPH) shares moved upwards by 27.35% to $0.88. UpHealth's stock is trading at a volume of 1.0 million shares as of 13:31 EST. This is 274.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $129.1 million.
- Inotiv (NASDAQ:NOTV) stock increased by 24.45% to $25.8. Inotiv's stock is trading at a volume of 369.4K shares as of 13:31 EST. This is 145.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $658.2 million. As per the press release, Q3 earnings came out yesterday.
Losers
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
